News

Powerpatent Launches Advanced Technology To Automate And Streamline Patent Application Processes
Patent Transactions 2024. PowerPatent Issued Patent. Powerful Idea. SaaS Conference and PowerPatent. USPTO PowerPatent Semin ...
Thiogenesis Receives Confirmatory Guidance on IMPD for Pediatric MASH Phase 2a Clinical Trial in Europe and Core Patent Granted in EU
Thiogenesis Therapeutics, Inc. (TSXV: TTI) (OTCQX: TTIPF), a clinical-stage biopharmaceutical company developing next-generation thiol-based therapies for mitochondrial disease and pediatric metabolic ...
Grace Therapeutics Announces Submission Of New Drug Application To U.S. Food And Drug Administration For Gtx-104
Submission Seeks Approval of GTx-104 in the Treatment of Patients with aneurysmal Subarachnoid Hemorrhage (aSAH) Comprehensive Data Package ...
TMCnet14h
Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment
The first patient was enrolled at Yale School of Medicine’s Department of Psychiatry, marking a significant milestone in the trial.
Bipartisan bill seeks to ban Chinese AI from federal agencies, as U.S. vows to win the AI race
A bipartisan group of lawmakers on Wednesday vowed to keep Chinese artificial intelligence systems out of federal agencies while pledging to ensure the U.S. will prevail against China in the global ...
TMCnet6d
LeddarTech Received Notice from Nasdaq Regarding Delisting and Announces Filing under the Bankruptcy and Insolvency Act in Canada
LeddarTech ® Holdings Inc. (“LeddarTech” or the “Company”) (Nasdaq: LDTC), an AI-powered software company recognized for its innovation in advanced driver assistance systems (ADAS) and autonomous ...
LiveLaw6d
Once Arbitration Commences After Failure Of Conciliation Under MSME Act, It Cannot Be Reinitiated By Halting Arbitration: Calcutta High Court
The Calcutta High Court bench of Justice Sabyasachi Bhattacharyya has held that once arbitral proceedings commenced under ...
PharmiWeb1d
Strong demand for Formycon 2025/2029 Bond leads to early closing of subscription period
Issue of Debt/BondStrong demand for Formycon 2025/2029 Bond leads to early closing of subscription period 24.06.2025 / 19:50 CET/CESTThe issuer is solely responsible for the content of this ...